Intranasally administered muse cells attenuate neurodegeneration in Parkinson’s disease

Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang · 2025

Read Intranasally administered muse cells attenuate neurodegeneration in Parkinson’s disease by Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729229.txt.

Description

Zhe Lu and seven co-authors deliver stem cells through the nose in a Parkinson's study from two thousand twenty-five. The disease kills dopamine neurons deep in the brain, behind a barrier most cells cannot cross. Muse cells, a hardy stem cell type, home to damage unusually well.

In a lab barrier model, an inflammatory signal raised a lipid cue that loosened the barrier and let muse cells through. In mice modeling Parkinson's, nose-delivered muse cells reached the brain better than ordinary stem cells. Once there, they could turn into cells bearing the key dopamine enzyme. The authors present the nose route and the homing signal as a delivery strategy worth developing. Human work remains ahead.

Catalog record

CREATORZhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12729229

Browse the full library · About the Tower of Babel